On the other hand, we succeeded in showing that the DFS of patients with high IL-6 was significantly poorer than that of patients with lower IL-6, and we believe that the most important result of the present study was finding that high serum IL-6 was a risk factor for CRC recurrence, including stage II patients. Here, IL6 is linked to colorectal carcinoma.